Avicanna to go public on CSE

Avicanna Inc. has filed a preliminary non-offering preliminary prospectus for a proposed initial public offering by way of qualifying the issuance of 540,484 units upon conversion of 540,484 special warrants issued on December 13, 2018 at $8.00 per special warrant.

Avicanna has targeted CSE as the exchange on which it will likely seek a listing.

Toronto based Avicanna aims to establish itself as a leader in the global medical cannabis industry through product discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure.

Avicanna has two wholly-owned subsidiaries, My Cannabis, an Ontario corporation, and Avicanna LATAM a corporation governed by the laws of Colombia. It holds a 70% controlling equity interest in Sativa Nativa S.A.S., a 60% controlling equity interest in Santa Marta Golden Hemp S.A.S, both governed by the laws of Colombia.

Avicanna has raised over $13 million since its inception in November 2016.

photo credit: Avicanna

Ted Liu

Ted Liu, M.Sc. (Mining, Queen's), MBA (Finance, Toronto), is the Editor of Private Capital Journal, CanadaMetals.ca, TechWire.ca, and the former Editor of Canadian Private Equity. Ted has been passionately tracking Canadian private capital industry since 1992, having most recently served as Research Director for The Canadian Venture Capital and Private Equity Association (CVCA).

Ted is the architect of CVCA infobase, and is the architect of CPE Media's Financings.ca, Canada's most sophisticated and advanced all private capital and public market financing database.